Does Insurance Cover Weight Loss Surgery? Medicare, Medicaid, Commercial

Mostly yes. Medicare has covered bariatric surgery since February 21, 2006 under National Coverage Determination 100.1^[1]. Most major commercial insurers cover it at BMI ≥ 35 with comorbidity (or BMI ≥ 40 alone), and approximately 46 of 50 state Medicaid programs cover at least one bariatric procedure as of the 2025 KFF survey^[8]. The friction is procedural: a 3-6 month medically supervised weight-management program, a bariatric-specific psychological evaluation, and surgery at an MBSAQIP-accredited center are the standard prior authorization gates. The exception is self-funded ERISA employer plans, which can — and frequently do — exclude bariatric surgery as a benefit entirely.

At a glance

• Medicare: covered since February 21, 2006 under NCD 100.1. Roux-en-Y gastric bypass, BPD/DS, sleeve gastrectomy, and laparoscopic adjustable gastric banding. Required: BMI ≥ 35, at least one comorbidity, documented unsuccessful medical treatment, MBSAQIP-accredited facility^[1].
• Medicaid: approximately 46 of 50 state programs cover at least one procedure for adults^[8]. Adolescents are covered more broadly via EPSDT. Specific procedure menus and BMI floors vary state by state.
• Commercial insurance: almost every major carrier (UnitedHealthcare, Anthem, Aetna, Cigna, Humana, BCBS plans) has a written bariatric medical policy. Typical criteria: BMI ≥ 35 + comorbidity OR BMI ≥ 40, plus a 3-6 month supervised weight management program and a psych evaluation.
• ERISA self-funded plans: can exclude bariatric surgery entirely. Roughly 30-40% of US employer plans either exclude bariatric surgery or cap it so that it functions as an exclusion. The exclusion is contractual and not appealable on clinical grounds.
• 2022 ASMBS/IFSO indications update: formally lowered the recommended surgical threshold to BMI ≥ 35 alone (regardless of comorbidity) plus BMI 30–34.9 with metabolic disease. Commercial uptake has lagged — most insurers still use the older NIH 1991 thresholds^[2].
• If insurance denies: US cash-pay runs $15,000-$30,000+. Mexico medical tourism cuts cash cost 50-70% but carries a documented complication-management burden when patients return to US care^[9][10].

1. Medicare: NCD 100.1, the bedrock coverage policy

Medicare has covered bariatric surgery since National Coverage Determination 100.1 took effect on February 21, 2006. The NCD was the first explicit federal coverage policy for obesity treatment surgery, and it remains the policy floor that nearly every state Medicaid program and most commercial insurers anchor their criteria to.

The original 2006 determination covered open and laparoscopic Roux-en-Y gastric bypass (RYGBP), open and laparoscopic biliopancreatic diversion with duodenal switch (BPD/DS), and laparoscopic adjustable gastric banding (LAGB). Sleeve gastrectomy was added via subsequent NCD revisions as the procedure became the dominant bariatric operation in the US. The covered indication, verbatim from the NCD, requires that the beneficiary has a body mass index of 35 or greater, has at least one comorbidity related to obesity, and has been previously unsuccessful with medical treatment for obesity^[1].

The NCD originally required surgery at a facility that was either an American College of Surgeons Level 1 Bariatric Surgery Center (program standards in effect February 15, 2006) or an American Society for Bariatric Surgery (now ASMBS) Bariatric Surgery Center of Excellence (same effective date). Those two certification programs were consolidated in 2012 into MBSAQIP — the Metabolic and Bariatric Surgery Accreditation and Quality Improvement Program, jointly administered by the American College of Surgeons and ASMBS. CMS formally removed the facility certification requirement from NCD 100.1 in 2013, but in practice nearly every Medicare Administrative Contractor still expects MBSAQIP-accredited facilities through local coverage determinations and quality reporting requirements.

Medicare Advantage plans (Part C) must cover everything traditional Medicare covers, so NCD 100.1 sets a floor for Medicare Advantage as well. Plans may apply additional prior authorization but cannot deny on more restrictive clinical criteria than the NCD itself permits.

2. Medicaid: ~46 states cover, state-by-state variability

State Medicaid programs make their own bariatric coverage decisions, and the picture is far broader than the analogous GLP-1 coverage question (where only ~13 states cover for obesity). As of the KFF 2025 Medicaid survey, approximately 46 of 50 state Medicaid programs cover at least one bariatric procedure for adults meeting BMI plus comorbidity thresholds^[8]. The four to six states that historically have not covered bariatric surgery for adults rotate over time as budget cycles open and close coverage; check your specific state’s medical policy directly.

Most state Medicaid programs anchor their bariatric criteria to the Medicare NCD 100.1 floor: BMI ≥ 35 with comorbidity, documented unsuccessful medical treatment, surgery at an MBSAQIP-accredited center. Many states layer on additional requirements — most commonly a 3-month or 6-month preoperative medically supervised weight management program, a bariatric-specific psychological evaluation, smoking cessation documentation, and nutritionist counseling.

Adolescents are covered substantially more broadly under EPSDT (Early and Periodic Screening, Diagnostic, and Treatment) — the federal Medicaid mandate that requires state Medicaid programs to cover medically necessary care for beneficiaries under 21, including bariatric surgery when clinical criteria are met. Adolescent bariatric programs at major children’s hospitals routinely accept Medicaid even in states where adult bariatric coverage is restrictive.

3. Commercial insurance: variable, employer-driven

Every major commercial insurer publishes a written bariatric medical policy. UnitedHealthcare, Anthem BCBS, Aetna, Cigna, Humana, BCBS Federal Employee Program, Kaiser Permanente regional plans, and the regional BCBS associations all have bariatric medical policy documents available on their public provider portals. The clinical criteria across these documents are remarkably consistent and almost universally include the following:

• BMI threshold: BMI ≥ 35 with at least one obesity-related comorbidity (type 2 diabetes, hypertension, dyslipidemia, obstructive sleep apnea, cardiovascular disease, NAFLD, severe joint disease) OR BMI ≥ 40 without comorbidity. This tracks the older NIH 1991 NIH Consensus Statement, not the newer 2022 ASMBS/IFSO recommendation of BMI ≥ 35 alone.
• Failed medical therapy: documented prior attempts at medical weight loss, typically including diet, exercise, behavioral counseling, and (increasingly) anti-obesity medication trials.
• Preoperative supervised weight management program: 3 or 6 months of documented medically supervised visits with monthly weight, dietary, and behavioral counseling.
• Psychological evaluation: a bariatric- specific psychiatric or psychological assessment to screen for untreated eating disorders, substance use, and the patient’s capacity to adhere to postoperative behavioral requirements.
• Nutritionist counseling: documented nutritionist or registered dietitian visits.
• MBSAQIP-accredited center: the surgery must be performed at an MBSAQIP-accredited facility by a bariatric surgeon in good standing.
• Procedures covered: sleeve gastrectomy, Roux-en-Y gastric bypass, BPD/DS, and most insurers cover revision surgery from a prior bariatric procedure. The single-anastomosis duodenoileal bypass (SADI-S) is the newest procedure and coverage is mixed.

The clinical criteria are not where the variation is. The variation is the BENEFIT — whether the employer-sponsored plan you’re enrolled in actually has bariatric surgery in its covered benefits package, or carves it out as an exclusion.

4. ERISA self-funded plans: bariatric exclusions are legal

About 65% of US workers with employer-sponsored insurance are in self-funded ERISA plans, where the employer pays claims directly and contracts with an insurance company (Aetna, BCBS, UnitedHealthcare, Cigna) only as a third-party administrator. Under ERISA, self-funded employers have broad discretion to define which benefits they cover and which they exclude. An estimated 30-40% of US employer plans — both self-funded and fully insured — either explicitly exclude bariatric surgery as a benefit OR apply per-member or per-procedure caps that function as exclusions in practice.

The most common forms of bariatric carve-out:

• Explicit benefit exclusion: the Summary Plan Description (SPD) lists “bariatric surgery,” “weight loss surgery,” or “treatment of obesity” under Exclusions and Limitations. No appeal will succeed against a written contractual exclusion.
• Lifetime maximum cap: a $5,000 or $10,000 lifetime cap on obesity treatment that does not approach the actual cost of bariatric surgery.
• Procedure-specific exclusion: covers revision surgery but not primary bariatric surgery, or covers sleeve and bypass but excludes BPD/DS and SADI-S.

Before assuming coverage, pull your Summary Plan Description and search it for the exact terms “bariatric,” “weight loss surgery,” “obesity treatment,” and “exclusions and limitations.” If your plan has a written exclusion, the path forward is either employer advocacy (some employers will add bariatric coverage during open enrollment if asked), spouse plan enrollment, or cash-pay alternatives.

5. The 6-month supervised weight management program: payer policy, not clinical guideline

The most-cited and most-frustrating prior authorization requirement is the 3-month or 6-month preoperative medically supervised weight management program — monthly documented visits with weight, diet, and behavioral counseling documentation. It is a payer-imposed administrative requirement, not a clinical guideline.

The ASMBS has explicitly opposed mandatory preoperative weight loss programs. The 2022 ASMBS/IFSO indications update, the most comprehensive society-level statement on bariatric surgery indications in two decades, recommends against conditioning surgical eligibility on prior medical weight loss attempts ^[2]. The clinical evidence does not support the program as outcome-improving — patients who complete the 6-month program have similar surgical outcomes to those who proceed directly.

The function of the requirement is administrative: it imposes attrition, delays the cost to the insurer’s current fiscal year, and serves as a documentation gate. Some commercial insurers have dropped the requirement entirely; some have shortened it from 6 months to 3 months; some have retained the full 6-month requirement. Check your specific plan’s bariatric medical policy for the current language.

6. Magnitude — surgery vs medical therapy vs GLP-1s

Insurance criteria are anchored in clinical magnitude. Bariatric surgery produces the largest, most durable weight loss in medicine, with mortality and metabolic outcomes that no medication has matched. The 2017 STAMPEDE 5-year follow-up randomized 150 patients with type 2 diabetes and BMI 27-43 to intensive medical therapy alone, bypass plus medical therapy, or sleeve plus medical therapy. At 5 years, glycemic targets were achieved in 5% of medical-only patients vs 29% of bypass and 23% of sleeve patients ^[3]. The Swedish Obese Subjects (SOS) study followed 4,047 patients for a mean of 10.9 years and reported a 29% reduction in all-cause mortality in the surgical arm vs matched controls ^[4]. Buchwald’s 2004 JAMA meta-analysis of 22,094 patients across 136 studies established the canonical surgical weight-loss magnitudes that still anchor insurance medical policies today^[5].

For comparison, the STEP-1 trial of semaglutide 2.4 mg reported a placebo-subtracted mean weight loss of −14.9% at 68 weeks ^[6], and the SURMOUNT-1 trial of tirzepatide 15 mg reported −20.9% at 72 weeks^[7]. Both medications produce weight regain on discontinuation, where surgery does not. The 2026 sequencing debate — try GLP-1 first or go straight to surgery — is unsettled clinically, but the 2022 ASMBS/IFSO indications explicitly recommend against conditioning surgery on prior pharmacotherapy ^[2].

7. The 2022 ASMBS/IFSO threshold update — and why insurance hasn’t caught up

The 2022 ASMBS/IFSO indications update was the first major society-level revision of bariatric surgery thresholds in 30 years, replacing the NIH 1991 Consensus Statement thresholds that had defined the field since the early 1990s. The update recommends:

• BMI ≥ 35 alone (regardless of comorbidity) qualifies for metabolic and bariatric surgery.
• BMI 30-34.9 with metabolic disease (type 2 diabetes, etc.) qualifies for metabolic and bariatric surgery.
• Pediatric/adolescent indications expanded — surgery is recommended for adolescents with severe obesity and appropriate comorbidities.
• Surgery should not be conditioned on prior pharmacotherapy or medically supervised weight management programs as a gatekeeping requirement ^[2].

Commercial insurance medical policies have been slow to adopt the new thresholds. Most major insurers’ bariatric medical policies as of 2025-2026 still operate on the older NIH 1991 criteria — BMI ≥ 35 with comorbidity or BMI ≥ 40 without. The 2022 ASMBS/IFSO update is cited as a useful appeal document when a patient at BMI 35-39 without traditional comorbidity is denied; the success rate of those appeals is variable.

8. If insurance denies — cash-pay and Mexico medical tourism

US cash-pay bariatric surgery costs run $15,000-$30,000+, with sleeve gastrectomy at the low end ($15,000-$25,000), Roux-en-Y bypass at $20,000-$30,000, and BPD/DS at $25,000-$35,000+. Some MBSAQIP-accredited centers offer cash bundle pricing that’s substantially lower than billed-charge rates. For the cost breakdown specifically, see our weight loss surgery cost guide.

Mexico medical tourism — primarily Tijuana, Monterrey, and Cancun — cuts cash-pay cost 50-70%. A sleeve gastrectomy package at a Tijuana clinic runs $4,500-$6,500 USD all-in (surgery, 2-3 night hospital stay, hotel recovery, ground transport from San Diego). The cost savings are real but carry documented risks:

• Complication-management burden: US academic centers near the border publish ongoing case series of patients returning home with anastomotic leaks, internal hernias, gastric pouch dilation, marginal ulcers, and nutritional deficiencies that then require US-side rescue surgery — frequently uninsured because the original procedure was foreign ^[9]. The Khan 2025 5-year retrospective series from an academic center near the US-Mexico border documents the operational scope of this complication-management workload.
• Follow-up access: postoperative bariatric care requires regular labs, nutritionist visits, and monitoring for years. Mexican clinics generally cannot provide that follow-up in the US, and US bariatric centers may not accept tourism-surgery patients for ongoing care.
• Accreditation variability: the Kim 2019 global bariatric tourism survey documents wide variability in facility accreditation, surgical volume, and complication-reporting practices across international bariatric tourism destinations ^[10]. If pursuing medical tourism, choose facilities with IFSO Center of Excellence or JCI accreditation and pre-arrange US-side follow-up before traveling.

9. Pre-authorization step-by-step — what your bariatric program will do

Most MBSAQIP-accredited bariatric programs have a dedicated bariatric coordinator or insurance navigator who runs the prior authorization on the patient’s behalf. The typical sequence:

1. Initial consultation with the bariatric surgeon, including a documented BMI measurement, comorbidity assessment, and surgical risk evaluation.
2. Insurance benefits verification by the bariatric coordinator — pulling the plan’s bariatric medical policy, confirming coverage is not excluded, and listing the required prior authorization documentation.
3. Multidisciplinary evaluation: psych eval, nutritionist evaluation, often a cardiology or pulmonology clearance depending on comorbidities.
4. Medically supervised weight management program (3 or 6 months as the plan requires), with monthly visits documenting weight, diet, exercise, and behavioral counseling.
5. Prior authorization submission to the insurer including the Letter of Medical Necessity, comorbidity documentation, multidisciplinary evaluations, and the supervised weight management program records. The insurer typically responds within 14-30 days.
6. Scheduling if approved. If denied, the program coordinator typically handles the internal appeal within the plan’s stated timeframe.

10. Appealing a denial — internal then external review

A bariatric denial is appealable through a defined process. The path:

1. Read the denial letter carefully. Identify the specific reason — wrong procedure code, BMI below threshold, missing comorbidity, incomplete supervised weight management program, or benefit exclusion. The fix depends entirely on the denial reason.
2. Internal appeal within the timeframe stated on the denial letter (typically 30-180 days). Submit a Letter of Medical Necessity from your surgeon, documented comorbidities with ICD-10 codes, BMI history, and primary- source citations to Medicare NCD 100.1 and the 2022 ASMBS/IFSO indications.
3. External review if the internal appeal fails. State insurance departments administer external independent review for fully insured plans; ERISA self- funded plans have a federal external review path under the Affordable Care Act’s claims and appeals regulations.
4. If the denial is a benefit exclusion — your plan does not cover bariatric surgery as a benefit — no clinical appeal will succeed. The exclusion is contractual. Options at that point are employer advocacy (request the benefit be added at open enrollment), spouse plan enrollment, switching to a Marketplace plan (most ACA Marketplace plans cover bariatric surgery), Medicare enrollment if age-eligible, or cash-pay alternatives.

11. Where this fits in the broader insurance landscape

Bariatric surgery coverage is structurally distinct from GLP-1 anti-obesity drug coverage even though the two are increasingly considered competing therapies. Coverage of bariatric surgery is far broader (Medicare since 2006, ~46 state Medicaid programs, most commercial plans) than coverage of GLP-1s for obesity (Medicare excluded by statute, ~13 state Medicaid programs, ~44-49% of large employers). For the GLP-1 side of the coverage landscape, see our GLP-1 insurance coverage explainer. For the head-to-head comparison of GLP-1 vs surgery as a treatment decision, see our bariatric surgery vs GLP-1 decision guide. For the cost breakdown if your plan denies, see our weight loss surgery cost guide. To check eligibility under your specific BMI and comorbidity profile, use our bariatric surgery eligibility checker. To see whether your specific employer covers bariatric surgery, use our insurance employer checker.

YMYL disclaimer

Bariatric surgery is a major irreversible operation with real perioperative and long-term risks. Insurance coverage policies change frequently and the specific terms of any individual plan may differ from the general categories described here. Always verify coverage with your specific insurance plan’s member services line and pull your plan’s bariatric medical policy document before making decisions. Talk to a bariatric surgeon, an obesity medicine specialist, and an in-network insurance coordinator before pursuing surgical treatment of obesity. Weight Loss Rankings does not provide medical or financial advice.